SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-006195
Filing Date
2023-03-10
Accepted
2023-03-10 16:43:14
Documents
13
Period of Report
2023-03-10
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dmtp20230310_8k.htm   iXBRL 8-K 26477
  Complete submission text file 0001437749-23-006195.txt   158449

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA dmac-20230310.xsd EX-101.SCH 3601
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dmac-20230310_def.xml EX-101.DEF 11517
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE dmac-20230310_lab.xml EX-101.LAB 15384
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dmac-20230310_pre.xml EX-101.PRE 11673
7 EXTRACTED XBRL INSTANCE DOCUMENT dmtp20230310_8k_htm.xml XML 2561
Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36291 | Film No.: 23724313
SIC: 2834 Pharmaceutical Preparations